Related Experiment Videos
[Genital papillomavirus infections]
1Service de dermatologie II, CHU Saint-Jacques, Besançon.
La Revue Du Praticien
|October 15, 1996
Summary
Human papillomavirus (HPV) infections are rising, particularly in young adults. Management of condylomas and related neoplasias relies on clinical evaluation, with immunosuppression being a key risk factor for recurrence.
Area of Science:
- Gynecology
- Dermatology
- Infectious Diseases
Context:
- Genital human papillomavirus (HPV) infections, including subclinical and latent forms, are increasingly prevalent globally.
- Condyloma acuminata incidence is rising, with highest rates among 16-25 year olds.
- A direct correlation exists between the number of sexual partners and HPV presence.
Purpose:
- To review the epidemiology, clinical presentation, and management of HPV infections and associated neoplasias.
- To highlight the role of specific HPV types in low-grade and high-grade intraepithelial neoplasia (IN).
- To emphasize the significance of immunosuppression as a risk factor for disease progression and recurrence.
Summary:
- Clinical HPV infections like condylomas are recognized, but acetowhite lesions require colposcopy.
- High-grade IN (CIN, VIN, AIN, PIN) is linked to oncogenic HPV types 16/18, while low-grade IN and condylomas are associated with low-risk HPV types 6/11.
- Routine HPV-DNA typing is generally not required; management relies on clinical and microscopic evaluation.
Impact:
- Immunosuppression is a critical risk factor for the development, progression, and recurrence of HPV-related conditions.
- Despite treatment, recurrence rates for condylomas and neoplasias approach 30%.
- Regular clinical follow-up post-treatment is essential to prevent recurrence and neoplasia development.